Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): a report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG) - Bisogno, G; De Salvo, G L; Bergeron, C
J Clin Oncol 2018;36;